VectivBio AG logo

VectivBio AG Employee Directory

Biotechnology ResearchBasel-Stadt, Switzerland51-200 Employees

VectivBio AG is a Basel, Switzerland-based clinical-stage biotechnology company focused on rare diseases and targeting conditions with clearly defined biology through transformative therapeutics. It originated in 2019 as a spinout from Therachon, a company whose achondroplasia program was acquired by Pfizer. The firm’s lead program addresses Short Bowel Syndrome, and its collaboration strategy includes an exclusive license with Asahi Kasei Pharma to develop apraglutide for multiple indications, including SBS with intestinal failure and steroid-refractory acute graft-versus-host disease, with potential future Japan indications. In 2023, VectivBio announced a merger with Ironwood Pharmaceuticals. The company employs 51 to 200 people and maintains a website at vectivbio.com.

Find VectivBio AG employees' phone numbers or email addresses

VectivBio AG Global Highlights

Location
Employees

Europe
10

Minus sign iconPlus sign icon
  • Switzerland
    6
  • Spain
    2
  • France
    1
  • Poland
    1

North America
1

Minus sign iconPlus sign icon
  • United States Of America
    1

VectivBio AG's Leadership

  • Stylized image of a person
    C. D.
    Chief Financial Officer
    Phone icon
  • Stylized image of a person
    D. F.
    Head, Talent Attraction
    Phone icon
  • Stylized image of a person
    M. B.
    Director, Clinical Process Lead
    Phone icon
  • Stylized image of a person
    J. Z.
    Board Observer
    Phone icon
  • Stylized image of a person
    K. G.
    Legal Consultant
    Phone icon

VectivBio AG Employee Metrics

100%
50%
0%
2026
2025
  • Sales
  • Business Development
  • Consultant
  • Recruiting
  • Accounting
  • Other
  • Administrative

Contact profiles from VectivBio AG

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    C. D.
    Chief Financial Officer
    Phone icon
    Jun 24, 2024
  • Stylized image of a person
    D. F.
    Head, Talent Attraction
    Phone icon
    Switzerland
    Jul 16, 2025
  • Stylized image of a person
    M. B.
    Director, Clinical Process Lead
    Phone icon
    Switzerland
    Jun 29, 2026
  • Stylized image of a person
    J. Z.
    Board Observer
    Phone icon
    FranceParis
    Jun 19, 2026
  • Stylized image of a person
    K. G.
    Legal Consultant
    Phone icon
    SpainMadrid
    Jun 24, 2026

Frequently Asked Questions

What is VectivBio AG known for?

Minus sign iconPlus sign icon
VectivBio AG was founded in 2019 operates in the Biotechnology Research industry. Explore VectivBio AG's company overview page for more information.

What is VectivBio AG's most common email format?

Minus sign iconPlus sign icon
VectivBio AG employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more VectivBio AG email formats with LeadIQ.

How many employees does VectivBio AG have currently?

Minus sign iconPlus sign icon
VectivBio AG has approximately 61 employees as of July 2026. These team members are located across 2 continents, including EuropeNorth America.

Who are VectivBio AG's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, VectivBio AG's key employees include:

  • Chief Financial Officer: C. D.
  • Head, Talent Attraction: D. F.
  • Director, Clinical Process Lead: M. B.
  • Board Observer: J. Z.
  • Legal Consultant: K. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.